Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Zoll Medical Israel Ltd. currently has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. This indicates a targeted prosecution effort for its medical and mechanical technologies. The workload is divided between 2 distinct examiners, with each examiner handling one of the pending matters.
The portfolio is active in 2 distinct art units, suggesting that the 2 pending actions involve different technical specializations within the broader medical device field. The busiest examiner, BERTRAM, ERIC D, is responsible for 1 pending office action.
With 2 pending office actions, 2 distinct examiners, and 2 distinct art units, the portfolio is completely distributed. There is no overlap in the personnel or the specific patent office divisions reviewing the company's current applications. This structure requires a customized approach for each action, as the 1 pending office action assigned to the busiest examiner represents only half of the total pending workload.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Double-patenting + other | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BERTRAM, ERIC D | 1 | 81.2% | +12.4% |
| SCHMITT, BENJAMIN ALLYN | 1 | 8.3% | +40.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18370590 | Systems, Devices, and Methods for Cardiac Diagnosis and/or Monitoring | BERTRAM, ERIC D | 31d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17643439 | CONTEXTUAL BIOMETRIC INFORMATION FOR USE IN CARDIAC HEALTH MONITORING | SCHMITT, BENJAMIN ALLYN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18370590 | Systems, Devices, and Methods for Cardiac Diagnosis and/or Monitoring | BERTRAM, ERIC D | 31d overdue |
| 17643439 | CONTEXTUAL BIOMETRIC INFORMATION FOR USE IN CARDIAC HEALTH MONITORING | SCHMITT, BENJAMIN ALLYN | — |
| Art Unit | Apps |
|---|---|
| 3792 | 1 |
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18370590 | Systems, Devices, and Methods for Cardiac Diagnosis and/or Monitoring | BERTRAM, ERIC D | 3792 | §102§103DP | Final Rejection | 31d overdue | Pending | Sep 20, 2023 |
| 17643439 | CONTEXTUAL BIOMETRIC INFORMATION FOR USE IN CARDIAC HEALTH MONITORING | SCHMITT, BENJAMIN ALLYN | 3796 | §103 | Final Rejection | — | Pending | Dec 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial